drugset / Trial / NCT00287833

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men

NCT00287833 ↗

Phase 1 Completed 20 enrolled National Cancer Institute (NCI)
RandomizedSingle-groupDouble-blindPrevention

Summary

This randomized phase I trial is studying the side effects and best dose of Bowman-Birk inhibitor concentrate in preventing cancer in healthy men. Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of Bowman-Birk inhibitor concentrate may prevent cancer.

Timeline

Start
2006-01
Primary completion
2007-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bowman-Birk inhibitor concentrate Unknown — Oral